“Over the last two years we have seen an increasing demand for our services from customers in the US, as well as recognizing the huge potential for future growth in the North American market,” said Andrew Henderson, sales and marketing director at Sterling Pharma Solutions.
According to the contract development and manufacturing organization (CDMO) – which was acquired by GHO Capital earlier this year – the North American market makes up 70% of its customer portfolio.
“The decision to acquire was driven by this demand and our desire to be able to offer our customers access to a local team,” Henderson added.
The new facility is located close to the Research Triangle Park in North Carolina and will be able to cater to smaller volumes, Henderson said, “Adding the facility to our portfolio gives us a solid platform to pursue our business ambitions.”
Since 2016, Sterling has more than doubled its sales after a management buy-out, according to the CDMO.